dengu
viru
common
arbovir
infect
human
tropic
subtrop
region
world
review
briefli
describ
challeng
present
dengu
emerg
diseas
increas
geograph
distribut
sever
despit
significantli
underreport
world
health
organ
case
definit
gener
sever
manifest
infect
dengu
haemorrhag
fever
dhf
controversi
name
dhf
someth
misnom
diseas
infrequ
result
frank
haemorrhag
hallmark
dhf
actual
plasma
leakag
exist
four
close
relat
dengu
viru
serotyp
contribut
difficulti
diagnosi
origin
antigen
sin
serolog
respons
infect
exist
multipl
serotyp
result
sever
diseas
upon
second
infect
complic
vaccin
develop
nevertheless
safe
effect
vaccin
greatest
prospect
stem
tide
dengu
publish
elsevi
bv
behalf
intern
societi
chemotherapi
four
serotyp
dengu
viru
belong
flavivirida
famili
flaviviru
genu
denv
transmit
aed
spp
mosquito
primarili
ae
aegypti
also
ae
albopictu
dengu
diseas
especi
promin
tropic
subtrop
area
world
ae
aegypti
notabl
success
occupi
ecolog
nich
alongsid
human
infect
dengu
viru
may
asymptomat
caus
nonspecif
viral
syndrom
dengu
fever
df
dengu
haemorrhag
fever
dhf
df
almost
alway
selflimit
debilit
ill
gener
defin
fever
two
headach
retroorbit
pain
myalgia
arthralgia
rash
leucopenia
haemorrhag
manifest
petechia
dhf
defin
fever
haemorrhag
manifest
thrombocytopenia
plasma
leakag
pleural
effus
ascit
haemoconcentr
hypoproteinaemia
case
increas
number
sever
geograph
spread
estim
million
case
df
million
case
dhf
death
annual
approxim
billion
peopl
world
popul
countri
risk
opinion
assert
contain
herein
privat
view
author
constru
reflect
offici
view
unit
state
armi
unit
state
depart
defens
email
address
robertgibbon
afrimsorg
classif
scheme
df
dhf
use
sinc
revis
criteria
origin
develop
classif
df
dhf
also
help
distinguish
dengu
dhf
caus
febril
ill
purpos
dengu
classif
scheme
provid
clinician
clinic
criteria
recogn
sever
dengu
ill
report
system
base
clinic
criteria
concern
classif
adequ
face
rapidli
emerg
dengu
background
particular
concern
sever
diseas
meet
dhf
criteria
diseas
manifest
need
test
complet
blood
count
chest
radiograph
often
multipl
time
point
resourcepoor
area
effect
intervent
test
result
diseas
manifest
one
problem
current
criteria
interpret
mean
df
mild
dhf
sever
although
true
dhf
gener
sever
df
latter
sever
outcom
includ
case
definit
polit
may
difficult
muster
resourc
address
dengu
df
seen
mild
anoth
problem
desir
classif
system
meet
need
surveil
public
health
plan
earli
discrimin
dengu
ill
requir
hospitalis
research
studi
dengu
pathogenesi
probabl
impract
meet
object
audienc
singl
classif
system
agre
name
dhf
sourc
confus
although
overt
haemorrhag
clinic
impress
featur
diseas
case
evid
haemorrhag
tendenc
criterion
dhf
patient
tendenc
detect
elicit
done
exampl
tourniquet
test
bedsid
test
capillari
fragil
blood
pressur
cuff
appli
inflat
midpoint
systol
diastol
blood
pressur
minut
test
posit
petechia
per
squar
inch
fact
frank
haemorrhag
rare
dhf
hallmark
diseas
vascular
leakag
propos
renam
diseas
dengu
plasma
capillari
leak
syndrom
new
name
could
help
direct
focu
clinic
attent
plasma
leakag
perhap
lead
reassess
best
way
detect
monitor
criteria
haemorrhag
tendenc
thrombocytopenia
could
monitor
prognost
valu
would
requir
determin
dengu
plasma
leak
syndrom
last
three
decad
increas
dengu
case
report
america
dhf
case
increas
despit
alreadi
extrem
high
rate
dengu
data
southeast
asia
region
show
case
period
increas
dengu
poorli
document
africa
asia
america
infect
hiv
malaria
domin
africa
assumpt
dengu
may
signific
health
threat
dhf
rare
report
may
result
rel
resist
african
sever
dengu
diseas
differ
african
asian
virus
still
known
much
dengu
diagnos
treat
fever
malaria
subclin
dengu
infect
common
import
diseas
transmiss
addit
burden
clinic
diseas
underestim
base
work
puerto
rico
estim
dengu
underreport
factor
factor
year
age
compar
incid
dengu
diseas
cohort
studi
amongst
patient
less
year
age
thailand
cambodia
nation
surveil
data
provinc
year
averag
underestim
total
inpati
dengu
case
thailand
cambodia
respect
unpublish
data
data
indic
although
dengu
regularli
report
mani
countri
nation
surveil
data
gross
underestim
true
burden
diseas
role
aed
spp
mosquito
transmiss
dengu
may
seem
surpris
find
dengu
arid
region
ae
aegypti
notabl
success
ecolog
nich
alongsid
human
urbanis
foster
increas
ae
aegypti
rapid
human
popul
growth
overwhelm
exce
sanit
capabl
result
breed
site
garbag
area
water
storag
vessel
increas
number
dengu
outbreak
circul
serotyp
seen
normal
arid
region
saudi
arabia
part
india
iron
australia
concern
reintroduct
ae
aegypti
southern
locat
occur
midst
drought
human
respons
instal
larg
domest
water
storag
tank
model
habitat
dri
region
southeast
australia
suggest
water
storag
tank
could
result
expans
rang
vector
increas
risk
dengu
transmiss
region
vector
control
limit
success
control
dengu
situat
singapor
illustr
control
may
sustain
singapor
dedic
substanti
resourc
year
dengu
prevent
aed
control
aed
premis
index
percentag
premis
posit
aed
breed
sinc
result
declin
transmiss
dengu
dhf
howev
ultim
result
dramat
lower
herd
immun
mean
less
forc
transmiss
need
diseas
outbreak
occur
ongo
viru
introduct
malaysia
locat
result
epidem
df
particularli
amongst
adult
like
young
children
present
symptomat
diseas
first
dengu
infect
diseas
incid
increas
iron
strict
vector
control
whilst
prevent
dhf
young
lead
df
older
popul
recent
report
geosentinel
site
six
contin
dengu
second
common
caus
system
febril
ill
exclud
diarrhoeal
diseas
return
travel
common
caus
identifi
travel
return
caribbean
south
america
south
central
asia
southeast
asia
dengu
occur
frequent
malaria
region
except
africa
central
america
anoth
studi
dengu
account
febril
ill
return
travel
case
hospit
dengu
appear
increasingli
diagnos
travel
frequenc
increas
last
decad
addit
number
invari
reflect
underreport
sinc
incub
period
dengu
usual
day
travel
may
becom
ill
travel
within
endem
countri
diseas
often
report
four
denv
serotyp
antigen
distinct
caus
similar
diseas
human
substanti
evid
dhf
associ
secondari
infect
serotyp
differ
individu
alreadi
expos
addit
dhf
infant
associ
wane
level
matern
antibodi
wide
accept
hypothesi
pathogenesi
dhf
set
antibodydepend
enhanc
ade
antidenv
igg
either
activ
passiv
acquir
enhanc
denv
infect
fc
receptorbear
cell
result
increas
infect
cell
mass
trigger
immunolog
wave
addit
evid
secondari
infect
denguespecif
memori
cell
may
reactiv
heterolog
serotyp
dengu
infect
expand
high
level
tcell
effector
mechan
includ
cytokin
product
lysi
infect
cell
could
result
direct
indirect
effect
caus
increas
vascular
permeabl
howev
latter
mechan
would
contribut
occurr
dhf
primari
infect
infant
also
evid
ade
may
play
role
caus
dhf
worsen
spectrum
dengu
ill
ade
shown
vitro
number
viru
famili
amongst
human
pathogen
vivo
evid
ade
promin
dengu
respiratori
syncyti
viru
rsv
infect
endem
region
risk
dhf
appear
highest
infant
describ
second
dengu
infect
howev
endem
region
dhf
risk
third
fourth
infect
appear
low
studi
cuba
interv
free
dengu
suggest
longer
interv
infect
may
increas
risk
dhf
interest
rel
risk
dhf
occur
infect
specif
sequenc
serotyp
infect
sequenc
serotyp
shown
result
dhf
except
follow
noteworthi
children
much
less
like
present
symptomat
primari
infect
suggest
often
requir
enhanc
virul
infect
one
denv
serotyp
provid
longterm
protect
serotyp
induc
antibodi
crossreact
heterolog
denv
serotyp
year
ago
phenomenon
origin
antigen
sin
neutralis
antibodi
respons
denv
describ
secondari
denv
infect
could
induc
higher
titr
antibodi
previou
infect
serotyp
current
infect
serotyp
found
serolog
test
secondari
infect
identifi
infect
serotyp
time
rang
depend
serotyp
case
rang
depend
serotyp
serolog
test
result
appear
match
like
prior
infect
serotyp
unpublish
data
effort
develop
dengu
vaccin
date
back
vaccin
develop
includ
live
vaccin
classic
attenu
vaccin
sitedirect
mutagenesi
vaccin
dengu
dengueyellow
fever
chimera
inactiv
vaccin
recombin
e
protein
subunit
purifi
inactiv
viru
dna
vaccin
frontrunn
enter
phase
trial
preexist
heterotyp
immun
risk
factor
dhf
success
vaccin
must
protect
four
serotyp
vaccineinduc
enhanc
major
stumbl
block
develop
flaviviru
coronaviru
paramyxoviru
lentiviru
vaccin
evid
ade
play
role
failur
inactiv
experiment
rsv
vaccin
immunolog
interfer
document
sever
multityp
vaccin
date
back
analog
dengu
situat
oral
polio
vaccin
contain
three
differ
serotyp
polio
viru
found
seroconvers
rate
exceed
monoval
polio
vaccin
significantli
reduc
serotyp
combin
trival
formul
adjust
dose
serotyp
tend
increas
seroconvers
rate
degre
unpredict
manner
imbal
seroconvers
final
overcom
administr
three
dose
multival
vaccin
similar
difficulti
encount
develop
dengu
vaccin
monoval
vaccin
higher
neutralis
antibodi
respons
combin
variou
multival
formul
oral
polio
vaccin
anticip
multipl
dose
vaccin
necessari
achiev
seroconvers
three
four
denv
serotyp
dengu
worsen
geograph
scope
sever
sinc
world
war
ii
indic
except
progress
vaccin
develop
discourag
trend
continu
dengu
nomenclatur
case
classif
debat
emphasis
plasma
leakag
defin
patholog
dhf
common
mechan
shock
exist
multipl
crossreact
serotyp
complic
dengu
ade
origin
antigen
sin
ade
particular
along
viral
interfer
made
vaccin
develop
challeng
prospect
safe
effect
vaccin
lead
hope
tide
dengu
stem
fund
fund
sourc
